f.espinoza

TL2 · Braga

Contributes reviews on supplier material. Based in Braga.

Joined 24 July 2025 · last posted 5d

90 posts, newest first. Showing up to 150.

What is genuinely unknown about long-term amylin agonism Replied, post #74 · Compounds › Cagrilintide & amylin analogues · 23 Jul 2026 · 19 likes Post #71 answers the question as asked. The question underneath it is different. On storage: aggregation-prone peptides are the ones where repeated warming and cooling…
[2026 update] Documenting an adverse event properly Replied, post #17 · Safety › Adverse events · 22 Jul 2026 · 16 likes A written record of an event with dates is what makes it assessable later, and memory reconstructs sequences that did not happen. The number is defensible. The…
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #79 · Practice › Dosing & titration · 19 Jul 2026 · 1 like Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Travelling with an injectable: documentation and practicalities Replied, post #41 · Access › International · 18 Jul 2026 · 4 likes This is the sort of exchange that makes the archive worth searching.
I joined for one answer and stayed for a year — what changed my mind Replied, post #88 · Start Here › Welcome · 17 Jul 2026 · 6 likes You do not need to introduce yourself before asking a question, and nobody will think worse of you for arriving with one. The introductions subcategory exists for…
What would change my mind about repair peptides: a specific answer Replied, post #25 · Compounds › Repair & healing peptides · 16 Jul 2026 · 9 likes Nothing in this subcategory is medical advice and several members here are describing experiments on themselves. Both of those things should be stated plainly rather…
Why the cheapest option is often not the cheapest Replied, post #14 · Access › Pricing · 29 Jun 2026 · 4 likes Filing a mild objection to the consensus on cheapest option. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #69 · Wellbeing › Sleep · 26 Jun 2026 · 3 likes Apnoea monitoring: if you have diagnosed or suspected sleep apnoea, periodic monitoring (annually) during weight loss is prudent because severity changes.
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #71 · Practice › Interactions · 25 Jun 2026 · 0 likes The arithmetic in post #69 is right; the assumption feeding it is the part to check. Nothing here is medical advice and an interaction question is one where the cost of…
Revisiting: Protein density versus volume when you cannot eat much Started this topic · Nutrition & Training › Protein & intake · 21 Jun 2026 · 4 likes Revisiting: Protein density versus volume when you cannot eat much Writing it up because I had to work it out twice and would rather nobody else did. I have spent a…
Why the timeline is on the right and not the left — what changed since Replied, post #57 · Meta › Site feedback · 18 Jun 2026 · 14 likes The reason timeline is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.
Why side effects reset at each escalation and that is not a failure Started this topic · Practice › Side effects · 14 Jun 2026 · 0 likes Why side effects reset at each escalation and that is not a failure — that is the question, and I have not found it answered plainly anywhere I have looked. The…
Hair shedding at month three: mechanism and time course — the long version Replied, post #27 · Practice › Side effects · 13 Jun 2026 · 0 likes Coming back to post #25, because the follow-up matters more than the original answer. I would keep Hair shedding and the decision it usually gets used for separate in…
Racemisation and why it is invisible to a mass measurement Replied, post #64 · Analytics › Impurities & related substances · 12 Jun 2026 · 14 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
About the Adverse events category Replied, post #3 · Safety › Adverse events · 7 Jun 2026 · 5 likes As a member rather than staff: the most useful thing I did when I started reading this category was to work through the tag pages rather than the topic list. The topic…
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #3 · Analytics › Home & field testing · 5 Jun 2026 · 0 likes Where the Cost versus information reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #13 · Evidence › Journal club · 3 Jun 2026 · 5 likes STEP 8 would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
Review: an evidence digest and the citation check that delayed it Replied, post #9 · Documentation › Doc review · 2 Jun 2026 · 1 like Adding the measurement that post #6 says would settle it. Check that each claim is sourced or explicitly labelled as community practice. Unmarked practice claims read…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #104 · Clinical › Bloodwork · 27 May 2026 · 0 likes The arithmetic on reference intervals is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone will catch it.
Reading a home test result without over-claiming Replied, post #36 · Analytics › Home & field testing · 9 May 2026 · 31 likes A control sample of known material run alongside is what turns a home test from an impression into a comparison. Without one you are calibrating against memory. One…
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #103 · Sourcing › Vendor reports · 4 May 2026 · 26 likes Adding the measurement that post #102 says would settle it. Photograph the vial and the label before opening. It costs ten seconds and it is what turns a report into…
Coming back to: A newcomer's list of things that confused me, and the fixes Replied, post #5 · Start Here › Welcome · 18 Apr 2026 · 29 likes Reading counts toward trust level, so lurking is not wasted. That is unusual and it is the reason the levels here track familiarity rather than volume. Adding a source…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #6 · Practice › Reconstitution · 17 Apr 2026 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
List price versus negotiated price versus what you pay Replied, post #11 · Access › Pricing · 8 Apr 2026 · 6 likes List price versus negotiated price has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that…
Journal club: is percentage weight change the right endpoint? Replied, post #44 · Evidence › Journal club · 6 Apr 2026 · 2 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions. I am reporting…
When a dose reduction is the correct response to a side effect Replied, post #8 · Practice › Dosing & titration · 27 Mar 2026 · 0 likes Writing down the date, the dose and the site each week takes fifteen seconds and is the single most useful record anyone here keeps. Memory reconstructs a titration…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #87 · Practice › Storage & stability · 25 Mar 2026 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
Revisiting: Maintainer handover: how it works Replied, post #51 · Meta › Wiki maintenance · 14 Mar 2026 · 16 likes Taking post #50 at face value and following it one step further. Volunteering for the review on this one. I use it monthly, I have a list of three things that have aged…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #60 · Pharmacology › Pharmacokinetics · 4 Mar 2026 · 15 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
GLP-1 receptor distribution: central and peripheral Replied, post #11 · Pharmacology › Receptor biology · 4 Mar 2026 · 13 likes GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin…
Follow-up: Search filters: what is missing Replied, post #44 · Meta › Site feedback · 2 Mar 2026 · 2 likes Two claims get bundled together under Search filters and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal…
Measurement error in a self-reported exposure Replied, post #101 · Evidence › Study critique · 26 Feb 2026 · 0 likes That reframing is the whole thing. The facts I already had.
Measurement error in a self-reported exposure Replied, post #98 · Evidence › Study critique · 26 Feb 2026 · 24 likes Building on post #97 rather than restating it. Criticism is more useful when it is narrower. "The trial answers a different question from the one being asked" is…
Revisiting: PCOS and metabolic overlap: what is and is not studied Started this topic · Clinical › Comorbidities · 18 Feb 2026 · 43 likes Revisiting: PCOS and metabolic overlap: what is and is not studied — setting out what I have, and where I think it stops being reliable. Trying to establish the…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #64 · Practice › Storage & stability · 10 Feb 2026 · 4 likes Post #63 is the version of this I will quote in future. One addition. Adding the boring version of Storing lyophilised material long term, because the interesting…
Stepping down deliberately, and how to do it without losing progress Replied, post #44 · Practice › Dosing & titration · 18 Jan 2026 · 30 likes Post #41 answers the question as asked. The question underneath it is different. Concentration and dose get conflated constantly in this subcategory. Changing how much…
Absence of evidence and evidence of absence Replied, post #13 · Research Methods › Statistics · 15 Jan 2026 · 1 like Genuine question rather than a rhetorical one: has anyone here actually observed absence of evidence, as opposed to read about it? The thread is long and I cannot tell.
Injection volume, overload, and peak distortion — one year on Replied, post #3 · Analytics › HPLC & UHPLC · 14 Jan 2026 · 3 likes Answering the question the opening post raises rather than the one it answers. Injection volume matters because column overload distorts peak shape, and an overloaded…
A partial dose because the pen emptied mid-injection Replied, post #54 · Practice › Administration · 9 Jan 2026 · 14 likes On post #52 — agreed on the reasoning, with one qualification. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it…
Aggregates and why a purity assay may miss them entirely Replied, post #36 · Analytics › Impurities & related substances · 29 Dec 2025 · 0 likes Trifluoroacetate is a counter-ion rather than an impurity, and it appears in the mass balance rather than in the chromatogram. Conflating the two accounts for several…
The headache that turns out to be dehydration Replied, post #84 · Nutrition & Training › Hydration & electrolytes · 6 Dec 2025 · 27 likes The reason headache keeps being re-asked is that the answer is conditional and people quote it without the condition. It is not that the answer is unknown.
Lurking for two months before posting: was that the right call? Replied, post #32 · Start Here › Welcome · 18 Nov 2025 · 29 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
Lipase elevation without symptoms: the interpretation problem Replied, post #14 · Clinical › Bloodwork · 18 Nov 2025 · 1 like A note on scope: what I am saying about lipase elevation without symptoms applies to the case in the first post and I would not extend it further without checking.
The anatomy of a question that gets answered within an hour — the long version Replied, post #106 · Start Here › How to Ask · 17 Nov 2025 · 31 likes It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of the question can usually be answered without the context. Worth…
[2026 update] What steady state means for the decision to escalate Replied, post #104 · Practice › Dosing & titration · 15 Nov 2025 · 27 likes Post #100 put the caveat in the right place and I want to underline it. I would call the community position on steady state likely rather than established, and I would…
EMA product information as a primary source Replied, post #46 · Regional › European Union · 9 Nov 2025 · 17 likes Regional stock held inside the union removes a customs question entirely for intra-union movement, which is a practical difference rather than a legal opinion. That is…
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #19 · Compounds › Tirzepatide · 8 Nov 2025 · 0 likes Building on post #18 rather than restating it. SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with…
MHRA statements, read directly Replied, post #27 · Regional › UK & Ireland · 6 Nov 2025 · 0 likes Worth separating MHRA statements as a question about the compound from MHRA statements as a question about the documentation. They get answered by different people and…
Gauge and length selection for subcutaneous injection Replied, post #47 · Devices › Syringes & needles · 5 Nov 2025 · 0 likes Practical answer on gauge and length selection, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether…
Revisiting: Absolute versus relative contraindications Replied, post #4 · Safety › Contraindications · 3 Nov 2025 · 4 likes Narrowing the opening post, because the general version has more than one answer. Research-use-only material has no labelling and therefore no contraindications listed,…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #79 · Documentation › Doc review · 22 Oct 2025 · 0 likes I read post #77 twice before replying, because I had assumed the opposite. Interdependencies: if updating one page requires updating related pages, posting that…
New subcategory: rationale and scope Replied, post #41 · Meta › Announcements · 17 Oct 2025 · 16 likes This follows post #38 rather than contradicting it. New subcategory was covered in the wiki last year and the page has a review date on it, which is a better starting…
Persistent vomiting and the threshold for seeking help Replied, post #51 · Safety › Adverse events · 15 Oct 2025 · 0 likes Nothing here is medical advice, and in this subcategory the phrase is doing more work than in any other on the site. Where I would look next, rather than where I would…
Managing an unplanned gap in supply — what changed since Replied, post #79 · Access › Shortages · 4 Oct 2025 · 15 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #16 · Lounge › Off topic · 2 Sep 2025 · 16 likes Unserious but true: I can now identify a certificate template at a glance and I have no professional use for that skill whatsoever. Worth saying I have only my own…
[2026 update] Splitting an overlong document into two Replied, post #27 · Documentation › Wiki requests · 25 Aug 2025 · 3 likes On post #23 — agreed on the reasoning, with one qualification. Splitting an overlong document sits at the boundary between what this community can usefully discuss and…
Reconstituting a multi-strength kit without mixing yourself up Replied, post #117 · Practice › Reconstitution · 16 Aug 2025 · 30 likes Taking reconstituting a multi-strength kit seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
A ten-fold dose error caught before injection — one year on Replied, post #51 · Devices › Syringes & needles · 2 Aug 2025 · 0 likes Worth separating two things that post #47 runs together. Buying a box of the wrong barrel size is the most common regret described in this subcategory, and the reason…
Comparing the STEP programme populations: who was actually enrolled — the long version Replied, post #3 · Compounds › Semaglutide · 1 Aug 2025 · 4 likes The opening post is right about the mechanism and I think understates the practical bit. Cardiovascular data in people without diabetes is the specific contribution of…
Coming back to: Official shortage notices and what they authorise Replied, post #69 · Access › Shortages · 26 Jul 2025 · 11 likes I read post #65 twice before replying, because I had assumed the opposite. A shortage of one presentation is not a shortage of all of them, and the published notices…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #88 · Practice › Reconstitution · 16 Jul 2025 · 16 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #18 · Compounds › Semaglutide · 24 Jun 2025 · 5 likes Taking post #15 at face value and following it one step further. The thing about semaglutide versus liraglutide that took me longest to accept is that a plausible…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #72 · Wellbeing › Mental health · 18 Jun 2025 · 0 likes Picking up post #69: that is the part I would want checked first. Marking my uncertainty on history of disordered eating explicitly. I am confident about the direction,…
Checking someone else's arithmetic: a worked example thread Replied, post #57 · Practice › Reconstitution · 14 Jun 2025 · 27 likes Confirming post #54 from a second method, which matters more than confirming it from a second person. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL…
Managing an unplanned gap in supply — what changed since Started this topic · Access › Shortages · 11 Jun 2025 · 17 likes On the subject in the title: Managing an unplanned gap in supply — what changed since Working notes rather than a conclusion. What changes if the standard account of…
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #4 · Analytics › HPLC & UHPLC · 4 Jun 2025 · 2 likes I read the opening post twice before replying, because I had assumed the opposite. A relative retention time against a known peak travels much better than an absolute…
Validating a calculator against hand arithmetic — what changed since Replied, post #105 · Data & Tools › Calculators · 1 Jun 2025 · 0 likes Where a calculator and your own arithmetic disagree, the productive move is to find which step differs rather than to decide which is right. Speaking for myself and not…
Residual solvents and scavengers: what is looked for Replied, post #15 · Analytics › Impurities & related substances · 21 Apr 2025 · 14 likes Summarising the residual solvents and scavengers thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction…
Coming back to: Why quantitation is the hard part, not detection Replied, post #5 · Analytics › Home & field testing · 8 Apr 2025 · 2 likes I came in to disagree and I am leaving without a disagreement.
Reading order for a first week here, and what to skip until later Replied, post #58 · Start Here › Welcome · 29 Mar 2025 · 1 like The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
Charge states for a 4 kDa peptide, worked through Replied, post #39 · Analytics › Mass spectrometry · 7 Mar 2025 · 15 likes Electrospray ionisation produces multiply charged ions. For a 4 kDa peptide you expect mostly 2+, 3+, and 4+ charge states. Reading an electrospray spectrum means…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #80 · Sourcing › Regulatory · 3 Mar 2025 · 1 like Generic or biosimilar entry depends on patent and exclusivity positions that are jurisdiction-specific and are frequently misreported. I have changed my mind on this…
Distinguishing a deletion sequence by mass alone Replied, post #13 · Analytics › Mass spectrometry · 23 Jan 2025 · 14 likes Confirming post #10 from a second method, which matters more than confirming it from a second person. Mass error in parts per million is (observed minus theoretical)…
What we do not know about retatrutide, listed explicitly Replied, post #60 · Compounds › Retatrutide · 18 Jan 2025 · 30 likes Nausea and vomiting were dose-related in the phase 2 work, as they are throughout this class. What is not established is whether the tolerability profile differs from…
Coming back to: An 18-month record including the parts that went badly Replied, post #8 · Outcomes › Progress reports · 16 Jan 2025 · 0 likes I read post #6 twice before replying, because I had assumed the opposite. 18-month record sits at the boundary between what this community can usefully discuss and what…
Second pass at: Regression to the mean in progress reports Replied, post #15 · Research Methods › Statistics · 3 Jan 2025 · 6 likes Building on post #14 rather than restating it. Medians and means diverge for skewed distributions, and most of the quantities discussed here are skewed. Which one a…
What changed in 2026, by region Replied, post #54 · Access › International · 2 Jan 2025 · 8 likes Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one.
Second pass at: Gauge and length selection for subcutaneous injection Replied, post #15 · Devices › Syringes & needles · 2 Jan 2025 · 0 likes Reusing a needle blunts it and there is no benefit to offset that. The second injection with the same needle is the one people describe as painful.
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #108 · Analytics › Method validation · 1 Jan 2025 · 20 likes Post #106 put the caveat in the right place and I want to underline it. Transfer between laboratories: a method can be transferred from one lab to another, but the…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #28 · Compounds › Oral incretins · 26 Dec 2024 · 25 likes Storage for a small molecule is a different problem from storage for a peptide: generally more robust, generally less temperature-sensitive, and generally more affected…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #6 · Compounds › Semaglutide · 15 Dec 2024 · 11 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
Injection-site reactions: describing them precisely enough to be useful Replied, post #46 · Practice › Side effects · 4 Dec 2024 · 3 likes This follows post #43 rather than contradicting it. The published rates come from populations that were titrated on a defined schedule with clinical supervision. Rates…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #52 · Compounds › Semaglutide · 28 Nov 2024 · 5 likes Trying to state the Semaglutide half-life position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes…
A promotion I argued against, and why I lost Replied, post #6 · Documentation › Doc review · 15 Nov 2024 · 15 likes Where the review finds the content is right but the framing overstates it, that is the most valuable catch available at this stage.
US compounding rules and how they changed Replied, post #46 · Regional › North America · 29 Oct 2024 · 0 likes Taking post #45 at face value and following it one step further. Prior authorisation criteria are usually published by the payer and reading them before the appointment…
Converting between mg/mL and units per dose, both directions Replied, post #63 · Practice › Reconstitution · 25 Oct 2024 · 7 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #94 · Clinical › Comorbidities · 24 Oct 2024 · 16 likes Something worth flagging about Hypertension improvement: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern…
Turnaround times and what they mean for a decision — one year on Replied, post #4 · Sourcing › Independent verification · 28 Sep 2024 · 12 likes Reading this Turnaround times thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
Where the four-week escalation interval comes from, and what it is not Replied, post #55 · Practice › Dosing & titration · 21 Jul 2024 · 4 likes Reading back through, this was answered upthread and I missed it. My fault.
Tracking a preprint to publication: a worked example — the long version Replied, post #10 · Evidence › Preprints · 24 Jun 2024 · 9 likes Version numbers on a preprint server matter. Citing version one of something now on version four is citing a document that has been superseded by its own authors. I…